Pharma Journalist -

Today, AnaBios announced a Research Collaboration Agreement (RCA) with the U.S. Food and Drug Administration (FDA) to study adult human primary cardiomyocytes as a reference for…
Read More...

Zydus Cadila, an innovation-driven global pharmaceutical company, and XOMA Corporation announced they have entered into a licensing agreement to advance an IL-2-based immuno-oncology…
Read More...

Nanoform, an innovative nanoparticle medicine enabling company, and Orion Corporation, a Finnish pharmaceutical company, announced a collaboration to apply Nanoform's award-winning CESS…
Read More...

ViiV Healthcare and the University of North Carolina at Chapel Hill announced a five-year, $20 million renewal of a unique, public-private research partnership solely focused on…
Read More...

AbbVie confirmed the company's activities in the fight to address the COVID-19 public health crisis, including supporting the experimental use of the HIV medicine, Kaletra/Aluvia…
Read More...

CEL-SCI Corporation announces that it is developing an immunotherapy with the potential to treat the COVID-19 coronavirus using its patented LEAPS peptide technology. The LEAPS peptides…
Read More...

SMi Reports: An Interview with Martin Everett, Chief Scientific Officer, at Antabio, who will be speaking at SMi’s highly anticipated 22nd Annual Superbugs & Superdrugs Conference…
Read More...

NAGASE & CO., LTD. and Osaka University have launched DDS Products Joint Development Research Chair, a course dedicated to research in the development of production methods of…
Read More...

SMi reports: Exclusive Chair letter invite released for Pre-Filled Syringes West Coast 2021 SMi Group’s 5th annual Pre-Filled Syringes West Coast conference is set to return on the…
Read More...

Revolutionary change in manufacturing strategies and device designs for new modalities are currently driving the inhalation industry forward. To achieve greater acceleration within this…
Read More...